Development of a single-cell sequencing platform enabling detection of both mutation and expression

Ryosaku Inagaki

Presentation information

Oral Session

Oral Session 1-9C AML: Genetic abnormalities

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Takashi Taga (Department of Pediatrics, Shiga University of Medical Science, Japan)

【Ｅ】

[OS1-9C-6] Development of a single-cell sequencing platform enabling detection of both mutation and expression

Ryosaku Inagaki^1,2,3, Masahiro Nakagawa^1,2, Yasuhito Nannya¹, Lanying Zhao¹, June Takeda¹, Akinori Yoda¹, Ayana Kon¹, Tetsuichi Yoshizato¹, Hisashi Tsurumi⁴, Hideki Makishima¹, Seishi Ogawa¹ (1.Department of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 2.DSK Project, Medical Innovation Center, Kyoto University, 3.Sumitomo Dainippon Pharma Co., Ltd., 4.Department of Hematology, Gifu University)

Abstract password authentication.
Password is written on a program and abstract book.